₹18.50
+3.06%NSE close, 16 Nov 2026
−63.94%
GALAXY MEDICARE is a small cap company, listed on NSE SME under the symbol GML. At ₹18.50 a share, the market values the whole company at ₹28 crore. NSE SME is the exchange's platform for small and medium companies, which report their results every half year.
In FY26, it reported sales of ₹40 crore and a net profit of ₹3 crore, an operating margin of 10.6%.
The market values the company at 9.6 times its profit over the last twelve months and 0.68 times its book value; its return on equity is 7.1% and its borrowings are 0.10 times its equity.
Promoters hold 73.36% of the shares. Foreign institutions hold 0.00%, and domestic institutions, mutual funds among them, 0.00%.
Over the past year the share price has fallen 16.1%, and it is 22.3% below its 52-week high.
Listed on NSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
₹ crore. Standalone figures: the company files no consolidated results.
| Line | 6M to Sep 2025 | 6M to Mar 2026 | 6M to Sep 2026 |
|---|---|---|---|
| Sales | 18.7 | 21.3 | 20.2 |
| Expenses | 15.9 | 19.9 | 18.5 |
| Operating profit | 2.9 | 1.4 | 1.7 |
| Operating margin | 15.3% | 6.4% | 8.4% |
| Other income | 0.3 | 1.0 |
The financial results for the period ended September 30, 2026.
The financial results for the period ended September 30, 2026.
Has informed regarding Submission of Certificate in relation to Non- Applicability of Compliance Report on the Corporate Governance Pursuant to Regulation 27(2) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 for the Quarter Ended on 30th…
A copy Srutinizers report of Annual General Meeting held on September 28, 2026. Further, the company has informed the Exchange regarding voting results.
| Interest | 0.1 | 0.2 | 0.2 |
|---|
| Depreciation | 0.3 | 0.3 | 0.4 |
|---|
| Profit before tax | 2.8 | 1.9 | 2.2 |
|---|
| Tax | 0.8 | 0.5 | 0.7 |
|---|
| Net profit | 2.0 | 1.4 | 1.5 |
|---|
| EPS (₹) | 1.70 | 0.92 | 1.01 |
|---|
₹ crore, financial years to March.
| Line | FY26 |
|---|---|
| Sales | 40.0 |
| Expenses | 35.8 |
| Operating profit | 4.2 |
| Operating margin | 10.6% |
| Other income | 1.3 |
| Interest | 0.3 |
| Depreciation | 0.6 |
| Profit before tax | 4.7 |
| Tax | 1.3 |
| Net profit | 3.4 |
| EPS (₹) | 2.25 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY26 | 6M to Sep 2026 |
|---|---|---|
| From operations | 1.8 | 0.7 |
| From investing | −13.9 | −0.3 |
| From financing | 12.1 | −0.4 |
| Spent on fixed assets | −1.6 | −0.4 |
| Free cash flow | 0.2 | 0.3 |
Margins, returns, debt, tax and cash.
| Line | FY26 |
|---|---|
| Net margin | 8.5% |
| Operating margin | 10.6% |
| Return on equity | 8.5% |
| Return on capital employed | 11.2% |
| Return on assets | 7.0% |
| Debt to equity | 0.10 |
| Interest coverage | 17.80 |
| Debt to assets | 0.09 |
| Current ratio | 4.24 |
| Quick ratio | 3.47 |
| Cash ratio | 1.81 |
| Asset turnover | 0.82 |
| Fixed asset turnover | 2.66 |
| Inventory turnover | 4.50 |
| Receivables turnover | 5.20 |
| Gross margin | 37.2% |
| Cash from operations to profit | 52.0% |
| Effective tax rate | 27.4% |
Proceedings of Annual General Meeting held on September 28, 2026
Notice of Annual General Meeting to be held on September 28, 2026
Record date for the purpose of DI is 11-Sep-2026.
Re - Appointment of PBM & Associates, Chartered Accountant as Internal Auditor of the Company for the Financial Year 2026-2027 With Effect From August 31, 2026.
The outcome of the Board Meeting held on August 31, 2026, wherein the Board approved the Notice of the 34th Annual General Meeting, including the date and time of the AGM, along with the Annual Report for the Financial Year 2025-26.
The Exchange had sought clarification from Galaxy Medicare Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the…
Has informed regarding Submission of Certificate in relation to Non- Applicability of Compliance Report on the Corporate Governance Pursuant to Regulation 27(2) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 for the Quarter Ended on 30th…
The Exchange has sought clarification from Galaxy Medicare Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the…
A copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.